奈达铂同期放化疗治疗局部晚期宫颈癌的疗效观察
The Curative Effect of Nedaplatin Concurrent Chemotherapy and Radiotherapy on Local Advanced Cervical Cancer
-
摘要: [摘要]目的 探讨奈达铂同期放化疗治疗局部晚期宫颈癌的疗效和毒副反应.方法 35例患者采用每周奈达铂30 mg/m2同期放化治疗,放疗的当天开始于每周静脉用药1 d,共用5周;放疗方法:采用直线加速器6Mev-X线行盆腔大野照射DT 30 Gy后改为盆腔四野照射DT 20 Gy,总剂量DT 50 Gy;于放疗第4周开始每周行后装治疗2次,DT 600 cGy/次,共7次,A点剂量达4 200 cGy,观察疗效和不良反应. 结果 奈达铂放化总有效率89%,95%CI0.089%~0.939%,临床获益率89%,95%CI0.086%~0.936%;随访24个月无进展生存率(PFS)和总生存率(OS)分别为80%和94%,95%CI0.072%~0.948%.结论 奈达铂同期放化疗效可靠,毒副反应安全可耐受.
-
关键词:
- [关键词]局部晚期宫颈癌 /
- 奈达铂 /
- 同期放化疗
Abstract: [Abstract]Objective To investigate the effect and toxicity of nedaplatin concurrent chemotherapy and radiotherapy on local advanced cervical Cancer.Methods The nedaplatin was given at a dose of 30 mg(m2.w) once a week for 5 weeks in 35 patients. External radiotherapy was given at a dose 30 Gy firstly and then was irradiated for another 20 Gy under the condition of A point by linear accelerator 6Mev-X, the total radiotherapy dose was 50 Gy. From the 4th week post radiotherapy, intracavitary irradiation at DT 600cGy/time was given for twice a week, and lasted for 7 times to a total dose 4 200 cGy for A point. The curative effect and adverse reactions were observed.Results The total effective rate and clinical benefits rate were both 89%.The 24 months disease-free survival and overall survival rate was 80%and 94%, respectively.Conclusion Nedaplatin concurrent chemotherapy and radiotherapy can get better effects and tolerated side-effects
点击查看大图
计量
- 文章访问数: 3501
- HTML全文浏览量: 1296
- PDF下载量: 456
- 被引次数: 0